Previous Article | Next Article 
Molecular and Cellular Biology, February 1999, p. 1539-1546, Vol. 19, No. 2
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
SH3P7 Is a Cytoskeleton Adapter Protein and Is
Coupled to Signal Transduction from Lymphocyte Antigen
Receptors
Oliver
Larbolette,
Bernd
Wollscheid,
Jutta
Schweikert,
Peter J.
Nielsen, and
Jürgen
Wienands*
Abteilung für Molekulare Immunologie,
Institut für Biologie III, Albert-Ludwigs-Universität
Freiburg, and Max-Planck-Institut für Immunbiologie, D-79108
Freiburg, Germany
Received 3 September 1998/Accepted 26 October 1998
 |
ABSTRACT |
Lymphocytes respond to antigen receptor engagement with tyrosine
phosphorylation of many cellular proteins, some of which have been
identified and functionally characterized. Here we describe SH3P7, a
novel substrate protein for Src and Syk family kinases. SH3P7 migrates
in sodium dodecyl sulfate-polyacrylamide gel electrophoresis as a
55-kDa protein that is preferentially expressed in brain, thymus, and
spleen. It contains multiple amino acid sequence motifs, including two
consensus tyrosine phosphorylation sites of the YXXP type and one SH3
domain. A region of sequence similarity, which we named SCAD, was found
in SH3P7 and three actin-binding proteins. The SCAD region may
represent a new type of protein-protein interaction domain that
mediates binding to actin. Consistent with this possibility, SH3P7
colocalizes with actin filaments of the cytoskeleton. Altogether, our
data implicate SH3P7 as an adapter protein which links antigen receptor
signaling to components of the cytoskeleton.
 |
INTRODUCTION |
Stimulation of the B-cell antigen
receptor (BCR) triggers a series of cellular responses, such as altered
gene transcription, changes in cell metabolism, and internalization of
BCR-antigen complexes (8). These events require the
activation of different signal transduction pathways. A few have been
identified but are only partly understood. Biochemical and genetic
evidence indicates a critical role for the early activation of protein
tyrosine kinases (PTKs) of the Src and Syk family (16). Upon
BCR aggregation, one or more of these PTKs phosphorylates
immunoreceptor tyrosine-based activation motifs (ITAMs) in the
cytoplasmic tail of the BCR signaling components Ig-
and Ig-
(29). An important function of phosphorylated ITAMs is the
binding of SH2 domains of cytoplasmic signaling proteins. SH2-mediated
binding of Src and Syk family kinases to phosphorylated ITAMs leads to
increased PTK activity and enhanced substrate phosphorylation (8,
16, 29).
Some PTK substrate proteins in activated B cells have been identified,
providing important insight into the molecular mechanisms of the
functional coupling of the activated BCR to certain signaling cascades.
Upon tyrosine phosphorylation, phospholipase C-
becomes activated
and hydrolyzes phosphoinositides. The resulting second messengers
induce elevation of intracellular Ca2+ and activation of
protein kinase C (8, 16). Other PTK substrates, such as HS1
and p120GAP, are implicated in the regulation of gene transcription and
activation of the ras/mitogen-activated protein kinase pathway,
respectively (14, 46). The reorganization of the actin
cytoskeleton in antigen-stimulated B and T cells is ITAM dependent
(6, 19) and requires tyrosine phosphorylation of Vav
(12, 15), a guanine nucleotide exchange factor for the Rho
family of small G proteins (7). The importance of
actin-dependent signaling pathways has been demonstrated by the recent
analysis of Vav-deficient mice. TCR-stimulated T cells from these mice show severe defects in cap formation, cytokine production,
Ca2+ mobilization, and cell cycle progression (12, 15,
37, 47). However, with the exception of Vav, little is known
about the intracellular effector molecules that could link antigen
receptor stimulation to components of the cytoskeleton.
Although it is likely that BCR-regulated effector proteins have a
defined subcellular localization, the structural organization of
signaling cascades within the living cell is largely unknown. We have
suggested that the resting BCR recruits and organizes its intracellular
effector proteins (such as PTKs and their substrates) into a multimeric
signaling complex (29, 42). This could allow the rapid and
selective activation of BCR-specific signaling pathways, even when
downstream elements are common to the BCR and other receptors. The
formation of signaling complexes seems to depend on the function of
adapter proteins (26, 39, 43). Adapter proteins do not
possess enzymatic activity but contain conserved sequence motifs of 60 to 140 amino acids which mediate specific protein-protein interactions
(25). These motifs were initially identified as regions of
similarity among different proteins. It is now known that many of the
amino acid motifs fold into a compact domain structure which functions
as a protein module that is largely independent of the surrounding
sequences (25). Two of the best-studied protein modules are
SH2 and PTB domains, which recognize phosphotyrosine-containing peptide
ligands (2, 22). SH3 and WW domains bind to proline-rich
peptides (3, 21), while binding of PH domains to
phosphoinositides can tether cytoplasmic proteins to the plasma
membrane (18).
In this report, we identify a 55-kDa phosphoprotein from activated B
cells, SH3P7, whose cDNA was previously isolated in a screen for novel
SH3 domain-containing proteins (35). Further analysis showed
that SH3P7 contains multiple sequence motifs for protein-protein
interactions. A region of sequence similarity to actin-binding
proteins, which we called SCAD, could represent a novel protein module.
Finally, confocal microscopy reveals an association of SH3P7 with
components of the actin cytoskeleton.
 |
MATERIALS AND METHODS |
Materials.
The phenotype and culture conditions of the
lymphoid cell lines and the mouse macrophage cell line S388 have been
described previously (42). NIH 3T3 fibroblasts were
maintained in Dulbecco modified Eagle high-glucose medium supplemented
with 10% fetal calf serum, 2 mM L-glutamine, 50 U of
penicillin per ml, and 50 mg of streptomycin per ml. Mouse splenic B
cells were enriched from freshly isolated spleens by depletion of
CD43+ cells by using the MACS system (Miltenyi Biotec,
Cologne, Germany). Immobilized PT66 antiphosphotyrosine-agarose beads
(Sigma-Aldrich, Deisenhofen, Germany) and soluble 4G10
antiphosphotyrosine antibodies (Upstate Biotechnology, Lake Placid,
N.Y.) were used for precipitation and immunoblot analysis,
respectively. Anti-Flag antibodies were purchased from Integra
Biosciences, Fernwald, Germany. Polyclonal anti-SH3P7 antibodies were
produced by immunizing rabbits with KLH-coupled peptides corresponding
to amino acids 334 to 352 (EPTYEVPPEQDTLYEEPPL) and 260 to 273 (APHPREIFKQKERAM) of the SH3P7 protein. The antibodies obtained
were (i) 85-B2 and 86-B2 and (ii) 87-B2 and 88-B2, respectively.
Protein biochemistry.
Stimulation of cells via their antigen
receptors or with pervanadate-H2O2,
immunoprecipitations, and Western blot analysis were described
previously (1, 42). Large-scale purification of
tyrosine-phosphorylated proteins and amino acid sequence analysis of
their peptides have been described previously (43). Briefly, a total of 1010 J558L
m7.1 cells were stimulated in
aliquots of 3 × 107 cells/ml for 3 min with 50 µM
pervanadate-H2O2, and precleared lysates were
subjected to immunoprecipitation with agarose-conjugated antiphosphotyrosine antibodies. Bound proteins were specifically eluted
with 50 mM phenyl phosphate-200 mM NaCl, concentrated, separated by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE),
and stained with Coomassie blue. The 55-kDa protein band was excised
and subjected to in-gel digestion with lysyl endopeptidase C (Lys-C),
and the resulting, high-pressure liquid chromatography-purified
peptides were sequenced (TOPLAB, Munich, Germany).
In vitro kinase assay.
Twenty micrograms of glutathione
S-transferase (GST) or GST fusion proteins was incubated
with baculovirus-expressed Lyn, Blk, or Syk for 15 min at 37°C in 500 µl of kinase buffer containing 50 mM Tris (pH 7.4), 5 mM
MnCl2, 0.1 mM NaVa3, and 200 µM ATP. Phosphorylated proteins were detected by 4G10 immunoblotting.
DNA constructs, purification of recombinant fusion proteins, and
transfections.
The mouse SH3P7 cDNA was amplified from
poly(A)+ RNA of J558L cells by reverse transcription-PCR
with the primer pair 5'-GCCAGGTCTCGGCCTCAC-3' and
5'-GGACCGTGGGGCGTGCCA-3'. The PCR product was cloned into pTZ19 via the SmaI restriction site (pTZ-SH3P7) and
sequenced. To produce constructs encoding fusion proteins between the
GST and SH3P7, a KpnI/BamHI restriction fragment
of pTZ-SH3P7 was isolated, and the single-stranded 5' and 3' ends were
removed by using the exonuclease and polymerase activities of the
Klenow enzyme, respectively. Subsequently, the blunt-end fragment was cloned in reverse orientation into SmaI-digested pUC19
(p19-SH3P7). To obtain pRP-SH3P7, a
KpnI/HindIII fragment of p19-SH3P7
encompassing the complete SH3P7 coding sequence was ligated via the
same restriction sites into pRP261, a derivative of pGEX-3X (Pharmacia,
Freiburg, Germany). Constructs coding for GST fusion proteins that
contain either amino acids 1 to 337 (pRP-SCAD) or 303 to 433 (pRP-SH3pp) were generated by deleting the
NdeI/XbaI fragment or the
KpnI/EagI fragment of pRP-SH3P7, respectively.
All constructs were transformed in E. coli DH10B, and the
expression of in-frame GST-SH3P7 fusion proteins of the predicted
molecular weight was confirmed by SDS-PAGE and immunoblot analysis with
anti-SH3P7 antibodies (data not shown). Induction and purification of
the fusion proteins was performed according to the manufacturer's
instructions, except that a French press was used to break up the bacteria.
Expression vectors for SH3P7-Flag.
The
BstXI/BamHI fragment of p19-SH3P7 was
replaced with annealed synthetic oligonucleotides
5'-GTGGAACTCATAGAGGACTACAAGGACGACGATGACAAGTGAG-3' and
5'-GATCCTCACTTGTCATCGTCGTCCTTGTAGTCCTCTATGAGTTCCACGTAG-3' (p19-SH3P7-Flag), and a KpnI/XbaI
fragment coding for the SH3P7-Flag protein was inserted 3' of the
cytomegalovirus promoter into pCDNA3 (Invitrogen, Carlsbad, Calif.).
The Quick Change system (Stratagene, La Jolla, Calif.) was used for
site-directed mutagenesis of single and double Y
F substitutions in
p19-SH3P7-Flag. Primer combinations are
5'-GAAGAAGAACCTACATTTGAAGTACCCCCAG-3' and
5'-CTGGGGGTACTTCAAATGTAGGTTCTTCTTC-3' for Y337F and
5'-CCAGAGCAGGACACCCTCTTCGAAGAACCACCACTGG-3' and 5'-CCAGTGGTGGTTCTTCGAAGAGGGTGTCCTGCTCTGG-3' for Y347F.
Mutations were confirmed by sequencing, and the
KpnI/XbaI fragment of each vector was cloned into
pCDNA3. For transient expression of SH3P7-Flag proteins, 3 × 107 K46 cells in 300 µl of RPMI were mixed with 15 µg
of plasmid DNA and electroporated (320 V at 950 µF) with a Bio-Rad
gene pulser. Analysis was performed after 36 h. The expression
construct encoding a fusion protein between the enhanced green
fluorescent protein EGFP and SH3P7 was created by inserting the
EcoRI/BamHI fragment of p19-SH3P7 into pEGFPC1
(Clontech, Palo Alto, Calif.) digested with the same enzymes.
Analysis of GFP-SH3P7 by confocal laser scanning microscopy.
NIH 3T3 cells were seeded on glass coverslides and transfected with
constructs for EGFP and EGFP-SH3P7 by using the CaPO4 method. Forty-eight hours after transfection, the slides were rinsed
with ice-cold phosphate-buffered saline (PBS)-0.1% NaN3 and cells were fixed with 3% paraformaldehyde on ice for 15 min. Slides were blocked on ice for 1 h with 10% fetal calf serum-PBS with gentle agitation. To stain the actin cytoskeleton, the slides were
overlaid with a 1:400 dilution of tetramethyl rhodamine isocyanate (TRITC)-labelled phalloidin (Sigma-Aldrich, Deisenhofen, Germany) for
1 h on ice. After being washed three times for 10 min each) with
0.1% PBS, slides were mounted in Fluoromount G (Southern Biotechnologies, Birmingham, Ala.) and sealed. Confocal laser scanning
microscopy was performed with a Leica Fluovert microscope equipped with
an argon/krypton laser by using the fluorescein isothiocyanate (FITC)
and TRITC filter settings to detect GFP and phalloidin, respectively.
 |
RESULTS |
Purification of SH3P7 from activated J558L
m7.1 cells.
Tyrosine-phosphorylated Lyn comigrates with a PTK substrate that could
not be depleted with anti-Lyn antibodies (data not shown). To identify
this (and other) PTK substrate(s), phosphotyrosine-containing proteins
were affinity purified from
pervanadate-H2O2-stimulated J558L
m7.1 B
cells with antiphosphotyrosine antibody columns and separated by
SDS-PAGE, and a Coomassie-stained protein of about 55 kDa was digested
with Lys-C. From two of the resulting peptide fragments, the amino acid
sequences FVILNWTGEGVNDVRK (Lys C-48) and ASGANYSFHK (Lys C-15) were
obtained. These sequences were compared to those in the databases and
found to be identical to amino acid sequences predicted from a murine
cDNA clone called SH3P7 (accession no. U58884 [35])
and a human EST sequence (accession no. AA687496). The Lys C-48 and Lys
C-15 peptides corresponded to amino acids 79 to 94 and 135 to 144 of
the mouse SH3P7 protein, respectively (see Fig. 1). The EST sequence
entry no. AA687496 is likely to represent a partial cDNA clone of the
human SH3P7 homologue. The presence of SH3P7 in antiphosphotyrosine precipitates from pervanadate-H2O2-stimulated
J558L
m7.1 cells suggested a signaling function for this protein in
activated B cells.
Sequence analysis of SH3P7.
The open reading frame in the
SH3P7 cDNA predicts a protein of 433 amino acids, with a calculated
molecular mass of 48.4 kDa and an isoelectric point of 4.8. We
performed an amino acid sequence comparison of SH3P7 with proteins from
the GenBank database and used the Hein method to align related
proteins. As shown in Fig. 1 (lower
panel), the N-terminal 140 amino acids of SH3P7 have significant
similarity to the actin-binding proteins drebrin, coactosin, and Abp-1
(9, 10, 33). The closest similarity is found between SH3P7
from mouse and human to the brain-specific drebrin proteins from
chicken, i.e., 43% sequence identity and 22% conservative changes.
Coactosin and Abp-1 from Dictyostelium discoideum and
Saccharomyces exiguus, respectively, show more sequence
variations. In all cases, a very high degree of similarity was found
between two conserved tryptophan residues, from which it is known that
they can act as central elements in protein domain folding.
Interestingly, coactosin consists of only 146 amino acids comprising
the entire region of similarity. In that part of the protein, the mouse
SH3P7 and the translated human EST sequence exhibit only four amino
acid changes. We conclude that the described region has similar
functions in SH3P7, coactosin, Abp-1, and drebrin. Using the initial
letters of the names of the four proteins, we propose the name SCAD for
this region. The SCAD regions of the four proteins may exhibit similar
folding patterns and may define a new type of protein module, such as
the SH2, SH3, or PH domain.

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 1.
SH3P7 is an adapter protein with multiple motifs for
protein-protein interactions. (Upper panel) Schematic representation of
the protein structures of SH3P7, coactosin, drebrin, and Abp-1. The
N-terminal region of sequence similarity was named SCAD. Amino acid
(aa) residues 170 to 250 of SH3P7 contain a high content of positively
(28.5%) and negatively (27.5%) charged amino acids (indicated by
+/ ) and may adopt an -helical structure. This part of the protein
contains four repeats of a hexamer which are also present in drebrin
and which have the consensus sequence R/KXEEXR. A putative SH3 domain
binding site (+PXXP+) and two consensus tyrosine phosphorylation sites
(YEVP-YEEP) are at positions 304 to 313, 337 to 340, and 347 to 350, respectively. The C-terminal SH3 domain has been reported previously
(35). The positions and sequences of the Lys C-48 and Lys
C-15 peptides are shown. Brackets indicate that the N-terminal lysine
residue is inferred after Lys-C digestion. Locations of peptide
sequences used for immunization are underlined. Protein structures are
drawn to scale. (Lower panel) Amino acid sequence alignment of the SCAD
regions together with the translated human EST sequence no. AA687496.
Related and identical (white dot) amino acid residues are boxed. Gaps
are indicated by black dots.
|
|
C-terminal of the SCAD region, SH3P7 is rich in positively and
negatively charged amino acids (Fig.
1, upper panel) which
may adopt an

-helical structure. This part of the protein contains
four
repeats with the consensus sequence R/KXEEXR. A putative
binding
motif for SH3 domains is at positions 304 to 313. It contains
the
consensus PXXP sequence, which is flanked on either side by
positively
charged amino acids. Two of 13 total tyrosine residues
of SH3P7 are
located within consensus phosphorylation motifs.
These tyrosine
residues are at positions 337 and 347 and are both
followed by proline
residues in the Y+3 and Y+4 positions. A C-terminal
SH3 domain explains
the ability of SH3P7 to bind proline-rich
peptides (
35). In
summary, our analysis revealed that SH3P7
bears a number of amino acid
sequence motifs which could mediate
specific protein-protein
interactions.
Expression analysis of SH3P7.
To functionally characterize
SH3P7, two peptide antiserum samples were generated and used for
immunoblot analysis of different mouse and human cell lines (Fig.
2a). SH3P7 is detected as a 55-kDa protein in the mouse B-cell lines 33-1-1, WEHI-231, K46
µm, and J558Lµm3 (lanes 1 to 4), which represent the pre-B, immature, mature,
and plasma cell stage of B-cell development, respectively. The human
SH3P7 was detected in Ramos B cells and Jurkat T cells (lanes 5 and 6).
Also, the mouse macrophage cell line S388 and NIH 3T3 fibroblasts
express SH3P7 (lanes 7 and 8). When lysates from different mouse
tissues were analyzed (Fig. 2b), the 55-kDa protein species was
detected in testis, heart, and lung (lanes 2, 5, and 6) and was most
prominent in brain, thymus, and spleen (lane 4, 7, and 8). Expression
in ovaries and muscle was weak or nonexistent (lanes 1 and 3). In
ovaries, muscle, and testis, our antibodies reacted with an
unidentified protein species of about 32 kDa which seems to be enriched
in ovaries. In summary, SH3P7 migrates in SDS-PAGE with an apparent
molecular mass of about 55 kDa and is expressed in all tested cell
lines and in a number of tissues. The difference between the predicted
molecular mass and the apparent molecular mass may result from the high content of charged amino acids, which can lead to retarded protein migration in SDS-PAGE. Using expression constructs that are based on
the SH3P7 cDNA and that encode a tagged fusion protein, we confirmed
that the apparent molecular mass of SH3P7 is 55 kDa (see below, Fig.
4d).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 2.
Expression of the SH3P7 protein in cell lines and
different tissues. Anti-SH3P7 immunoblot analysis of cleared cellular
lysates from approximately 106 cells of the indicated cell
lines (a) or with 2 mg of total protein from different mouse tissues
(b). In the experiments shown, the 87-B2 antibodies (see Materials and
Methods) were used. Identical protein patterns were detected by the
85-B2 antibody but not with preimmune serum (data not shown). The
apparent molecular masses of marker proteins are indicated in
kilodaltons.
|
|
Tyrosine phosphorylation of SH3P7.
To address the role of
SH3P7 in signal transduction, different B-cell lines and Jurkat T cells
were stimulated through their antigen receptors or with
pervanadate-H2O2. Tyrosine-phosphorylated proteins were immunoprecipitated and subjected to anti-SH3P7
immunoblotting (Fig. 3a). SH3P7 was
detected in antiphosphotyrosine precipitates from anti-immunoglobulin M
(IgM)-stimulated WEHI-231, K46
µm, and Ramos B cells (lanes 2, 4, and 8). As expected, a strong SH3P7 signal was observed in precipitates
from pervanadate-H2O2-stimulated J558Lµm3
(lane 6) and J558L
m7.1 (data not shown) cells. SH3P7 was also
present in antiphosphotyrosine precipitates from TCR-stimulated Jurkat
T cells (lane 10), although the signal was weaker than that obtained
from BCR-stimulated B cells. No SH3P7 signal was detectable in the
analysis of unstimulated cells (lanes 1, 3, 5, 7, and 9).

View larger version (31K):
[in this window]
[in a new window]

View larger version (29K):
[in this window]
[in a new window]

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 3.
SH3P7 is tyrosine phosphorylated in antigen
receptor-stimulated lymphocytes. (a) Antiphosphotyrosine precipitates
were prepared from the indicated cell lines, which were either
untreated (lanes 1, 3, 5, 7, and 9) or stimulated with 10 µg of
anti-mouse IgM antibodies (lanes 2 and 4) per ml, 50 µM
pervanadate-H2O2 (lane 6), 7.5 µg of
F(ab')2 fragments of anti-human IgM antibodies (lane 8) per
ml, or 10 µg of Okt-3 antibodies (lane 10) per ml. Purified
phosphoproteins obtained from 1.5 × 107 cells (lanes
1 to 4 and 7 to 10) or 5 × 106 cells (lanes 5 to 6)
were separated by SDS-PAGE and subjected to immunoblot analysis with
anti-SH3P7 antibodies (87-B2). (b) By using anti-SH3P7 antibodies
(87-B2) coupled to protein G-Sepharose, the SH3P7 protein was
precipitated from the indicated cell lines, which were treated as
described in the legend for panel a. Purified proteins from 1.5 × 107 cells (lanes 1 to 4) or 5 × 106 cells
(lanes 5 to 6) were analyzed by immunoblotting with antiphosphotyrosine
antibodies. The position of the endogenous 2am heavy chain of
K46 µm, which is detected by the secondary anti-mouse IgG
antibodies, is indicated. (c) Approximately 2 × 107
Ramos B cells (lanes 1 to 4) and 5 × 107 purified
splenic B cells (lanes 5 to 8) were either left unstimulated (lanes 1, 3, 5, and 7) or stimulated through their antigen receptors with 7.5 µg of F(ab')2 fragments from anti-human IgM antibodies
(lanes 2 and 4) per ml or with 15 µg of anti-mouse antibodies
(lanes 6 and 8) per ml, respectively. From these cells,
antiphosphotyrosine precipitates ( -YP; lanes 1 to 2 and 5 to 6) and
anti-SH3P7 precipitates ( -SH3P7; lanes 3 to 4 and 7 to 8) were
prepared and analyzed by antiphosphotyrosine immunoblotting. The
apparent molecular masses of marker proteins are indicated in
kilodaltons.
|
|
The results indicated that SH3P7 is involved not only in BCR- but also
in TCR-mediated signaling. However, purification of
SH3P7 with
antiphosphotyrosine antibodies could be due to the
association of SH3P7
with one or more phosphorylated protein(s)
or to tyrosine
phosphorylation of SH3P7 itself. To discriminate
between the two
possibilities, SH3P7 was immunoprecipitated from
unstimulated and
stimulated B-cell lines and analyzed by antiphosphotyrosine
immunoblotting. Figure
3b shows that purified SH3P7 from stimulated,
but not unstimulated, WEHI-231, K46

µm, and J558Lµm3 cells is
phosphorylated (lanes 1 to 6). The 60-kDa-62-kDa protein doublet
in
precipitates from K46

µm cells is derived from the endogenous

2am heavy chain (lanes 3 to 4). Control experiments with
metabolically
labeled cells showed that SH3P7 can be precipitated to
equal amounts
from unstimulated and stimulated cells (data not shown).
Collectively
the data show that SH3P7 is a substrate for activated PTKs
in
mouse B-cell lines. As shown in Fig.
3c, the same is true for
the
human B-cell line Ramos (lanes 3 and 4) and for purified B
cells of
mouse spleen (lanes 7 to 8). In this experiment, antiphosphotyrosine
precipitates (lanes 1 to 2 and 5 to 6) and anti-SH3P7 precipitates
(lanes 3 to 4 and 7 to 8) were analyzed in parallel. The comparison
revealed that SH3P7 migrates between two phosphoproteins, which
we
identified as the 53- and 56-kDa isoforms of tyrosine-phosphorylated
Lyn (data not shown). This finding confirms our initial observation
that an unidentified phosphoprotein comigrated with Lyn and might
explain why tyrosine-phosphorylated SH3P7 has been overlooked
thus
far.
SH3P7 is phosphorylated by Syk, Lyn, and Blk at tyrosines 337 and
347.
To test the ability of BCR-regulated PTKs to phosphorylate
SH3P7, anti-SH3P7 precipitates were subjected to an in vitro kinase assay with baculovirus-expressed Syk, Lyn, and Blk (Fig.
4a). Strong SH3P7 phosphorylation was
obtained with all three PTKs (lanes 6 to 8). After phosphorylation by
Syk and Lyn, a phosphoprotein was detected which migrates slightly
above the 55-kDa protein band of SH3P7 (lanes 6 and 7). This upper band
is likely to be a differently phosphorylated form of SH3P7, because a
similar protein doublet was recognized by anti-SH3P7 antibodies
(compare Fig. 3a, lanes 6 and 8). The 50-kDa phosphoprotein seen in the Syk kinase assay (Fig. 4a, lane 6) might result from a degradation product of SH3P7 or from a Syk substrate that was copurified with SH3P7. No phosphorylated proteins were detected when the same assays
were performed with rabbit control serum (lanes 1 to 4) or when
recombinant PTKs were omitted (lane 5). The latter finding indicates
that under our experimental conditions, no endogenous PTK
coprecipitated with SH3P7.

View larger version (33K):
[in this window]
[in a new window]

View larger version (24K):
[in this window]
[in a new window]

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 4.
Src and Syk family kinases can phosphorylate SH3P7 at
the YXXP motif. (a) Antiphosphotyrosine immunoblot analysis of proteins
precipitated from approximately 2.5 × 106
unstimulated J558L m7.1 cells with either rabbit control serum
(control; lanes 1 to 4) or anti-SH3P7 antibodies ( -SH3P7; lanes 5 to
8) and subsequently subjected to an in vitro kinase assay in buffer
alone (lane 1 and 5) or together with baculovirus-expressed Syk (lanes
2 and 6), Lyn (lanes 3 and 7), or Blk (lanes 4 and 8). (b)
Baculovirus-expressed Lyn (lanes 1 to 5), Blk (lanes 6 to 10), and Syk
(lanes 11 to 15) were used in an in vitro kinase assay without
additional proteins (lanes 5, 10, and 15) or together with either GST
(lanes 1, 6, and 11) or GST-SH3P7 fusion proteins that contain amino
acids 1 to 337 (lanes 2, 7, and 12), 1 to 433 (lanes 3, 8, and 13), or
303 to 433 (lanes 4, 9, and 14) of SH3P7. Phosphorylated proteins were
visualized by antiphosphotyrosine immunoblotting. (c) K46 cells were
transiently transfected with expression vectors bearing the gene
encoding wild-type flagged SH3P7 (wt-Flag; lane 2) or a flagged SH3P7
mutant with Y F substitutions at position 337 (FY-Flag; lane 3) or
347 (YF-Flag; lane 4) or positions 337 and 347 (FF-Flag; lane 5). After
stimulation of untransfected (lane 1) and transfected (lanes 2 to 5)
cells with 50 µM pervanadate-H2O2 for 5 min,
proteins were precipitated with anti-Flag antibodies and analyzed by
antiphosphotyrosine and anti-Flag immunoblotting (upper and lower
panel, respectively). The apparent molecular masses of marker proteins
are indicated in kilodaltons.
|
|
Next, we incubated recombinant PTKs with GST fusion proteins
encompassing SH3P7-derived amino acids 1 to 337, 1 to 433 (full
length), and 303 to 433. Antiphosphotyrosine immunoblotting
demonstrated
Lyn-, Blk-, and Syk-mediated phosphorylation of GST fusion
proteins
encompassing either the complete or the C-terminal 101 amino
acids
(Fig.
4b, lanes 3, 8, and 13 and lanes 4, 9, and 14). Even longer
exposure of the film did not reveal any phosphorylation of the
first
337 amino acids of SH3P7 (lanes 2, 7, and 13) or of GST
itself (lanes
1, 6, and 11). Thus, Lyn, Blk, and Syk are capable
of phosphorylating
SH3P7 in vitro only within the last 101 amino
acids. This suggests that
the two YXXP phosphorylation motifs
found in this part of the protein
contain the dominant phosphorylation
sites, i.e., Y337 and Y347. To
test this hypothesis, wild-type
or mutated SH3P7 carrying either single
or double Y

F substitutions
were expressed as Flag-tagged fusion
proteins in K46 cells. Following
stimulation of the cells with
pervanadate-H
2O
2, the fusion proteins
were
precipitated with anti-Flag antibodies and analyzed by
antiphosphotyrosine
and anti-Flag immunoblotting (Fig.
4c). In all
transfectants,
but not in mock transfected cells, the SH3P7-Flag
proteins were
produced and migrated in SDS-PAGE with the expected
molecular
mass of 55 to 56 kDa (lower panel, lanes 1 to 5). Expression
of
the wild-type SH3P7-Flag (lane 2) was lower than that of the mutants
(lanes 3 to 5). Phosphorylation was found for wild-type and for
singly
mutated SH3P7-Flag (Y337F or Y347F) but not for the doubly
mutated
SH3P7-Flag (Y337F and Y347F) (Fig.
4c, upper panel). Considering
the
low expression of the wild-type fusion protein, the similar
intensities
of the antiphosphotyrosine-derived signals demonstrate
that a single
Y

F mutation leads to reduced phosphorylation. In
summary, the
experiments identify tyrosine residues 337 and 347
as the only
phosphorylation sites in vitro and in
vivo.
SH3P7 is associated with the actin cytoskeleton.
To test for
a possible association of SH3P7 with the actin-containing
cytoskeleton, a fusion protein between GFP and SH3P7, GFP-SH3P7, was
transiently expressed in NIH 3T3 fibroblasts. Fibroblasts were chosen
because lymphocytes contain only a small cytoplasmic compartment, which
does not allow microscopic detection of subcellular structures.
Transfectants were fixed in 3% paraformaldehyde to preserve the
cytoskeleton architecture and were analyzed by confocal microscopy
(Fig. 5). The GFP-SH3P7 fusion protein
was found in the cytoplasm of the cells but not in the nucleus (Fig.
5a). It became organized into fiber-like structures which were also
stained by phalloidin (Fig. 5b). This compound binds specifically to
filamentous actin (F-actin) and hence stains the actin cytoskeleton.
Figure 5c shows that GFP-SH3P7 and F-actin fibers colocalize and that both proteins are enriched in submembraneous patches of the cortical cytoplasm. The GFP-SH3P7 and F-actin-containing fibers were destroyed following treatment of the cells with cytochalasin D (data not shown),
which disrupts the actin cytoskeleton. In contrast to what occurred
with GFP-SH3P7 transfectants, when NIH 3T3 fibroblasts expressing large
amounts of GFP only or a GFP-B-Raf fusion protein were fixed with
methanol to allow diffusion of cytosolic proteins, only a very faint
signal was detected in the two latter cell lines (data not shown). This
confirms that GFP and GFP-B-raf, but not GFP-SH3P7, are soluble
proteins and that not all GFP fusion proteins are anchored to
the cytoskeleton. We conclude that SH3P7 is directly or indirectly
associated with F-actin fibers and is thus a component of the
cytoskeleton.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 5.
Subcellular localization of SH3P7. NIH 3T3 fibroblasts
were transiently transfected with an expression vector bearing the gene
encoding a GFP-SH3P7 fusion protein (a to c). Forty-eight hours after
transfection, cells were fixed in 3% paraformaldehyde and stained with
TRITC-labelled phalloidin to visualize the actin-containing
cytoskeleton. Subsequently, confocal microscopy was performed by using
the FITC and TRITC filter settings to detect either GFP-SH3P7 (a) or
phalloidin-F-actin (b) conjugate, respectively. (c) Overlay of panels
a and b.
|
|
 |
DISCUSSION |
A 55-kDa protein was purified with antiphosphotyrosine antibodies
from pervanadate-H2O2-stimulated J558L
m7.1
cells. Amino acid sequences of two peptides matched to a GenBank cDNA
clone, called SH3P7 (35). Rabbit polyclonal antibodies were
generated and employed to characterize the protein. Expression of SH3P7 was found in many cell types and seems not to be restricted to a
particular stage of B-cell development. Studies with B-cell lines and
splenic B cells showed that upon BCR stimulation, SH3P7 is a direct
substrate for activated PTKs. Phosphorylation by Syk and Src family
kinases occurs at two consensus tyrosine phosphorylation motifs of the
YXXP type. Other sequence motifs in SH3P7 are the SH3 domain and the
SCAD region. The SCAD region comprises about 140 amino acids which have
significant sequence similarity to drebrin, Abp-1, and coactosin
(9, 10, 33). As shown for the latter proteins, our data
reveal an association of SH3P7 with actin fibers of the cytoskeleton.
The data identify SH3P7 as a BCR-regulated effector protein with
sequence motifs for constitutive and stimulation-dependent
protein-protein interactions which couple BCR activation to the cytoskeleton.
The sites of phosphorylation in SH3P7 are the two YXXP motifs (YEVP and
YEEP). Very similar phosphorylation motifs are also found in four other
adapter proteins which are known targets for activated PTKs in B
lymphocytes. These are Cbl (YDVP), p62dok (YELP and YDEP), Cas (7 × YDVP), and SLP-65 (YENP, YEPP, and YVVP). The proto-oncogene product
Cbl is a reported substrate for Lyn (23, 38) and was
originally discovered as the transforming gene v-cbl of the
murine Casitas NS-1 retrovirus (17). The p120GAP-associated protein p62dok is tyrosine phosphorylated in response to a variety of
stimuli, including BCR activation (5, 45). The
Crk-associated substrate Cas contains a total of 15 YXXP motifs
(32). For six of the seven YDVP sequences in Cas, the
sequence similarity to the SH3P7 motifs extends to the Y+4
position in that they all have a proline in that position
(YXXPP). The SLP-65 protein, which we have recently identified as
the B-cell analog of the T-cell adapter protein SLP-76, is the earliest
PTK substrate protein in activated B cells and may be part of a BCR
transducer complex (43). Thus, the family of YXXP-containing
adapter proteins has a key regulatory role in signal transduction and
can participate in cellular transformation. Upon tyrosine
phosphorylation, these proteins can be recognized by and bound to SH2
domain-containing proteins (25). SH2 domains bind their
phosphopeptide ligands in a sequence-specific manner. When a
phosphopeptide library was screened with different SH2 domains,
tyrosine-phosphorylated peptides having a proline residue in the Y+3
position were selected as high-affinity ligands by the SH2 domains of
Abl, Crk, and Nck (34). The SH2-mediated binding of these
proteins to phosphorylated YXXP sequences may nucleate the formation of
multimeric signaling complexes and may be one way all these proteins
contribute to cellular activation and/or neoplastic transformation.
Experiments are under way to test whether tyrosine-phosphorylated SH3P7
binds to one or more of the above-mentioned proteins during B-cell activation.
In addition to the transient protein-protein interactions mediated by
SH2-phosphotyrosine binding, the SH3 domain of SH3P7 can mediate a
stimulation-independent association to proline-rich proteins (11,
21, 28). SH3 domains are frequently found in proteins of the
cytoskeleton. The SH3 domain of SH3P7 is most closely related to that
of cortactin, HS1, and Abp-1 (data not shown). The SH3 domain is
separated from the N terminus of SH3P7 by a stretch of highly charged
amino acids containing four repeats of the consensus sequence R/KXEEXR.
The RE-rich hexamer is found in a number of other proteins, for
example, drebrins, troponin I, and caldesmon (data not shown), but not
in coactosin and Abp-1. This part of SH3P7 could adopt an
-helical,
rod-like structure, which may function to prevent an intramolecular
interaction between the C-terminal SH3 domain and the N-terminal part
of the protein, which contains the SCAD region.
Four features of the SCAD region strongly suggest that it represents a
new type of protein module which mediates the specific binding to
actin. First, the SCAD region is found in distantly related proteins
from different organisms, demonstrating that the structural folding of
the SCAD region is independent of surrounding sequences. This is
particularly evident in coactosin, where the entire protein is composed
of one SCAD region. Second, a very high degree of sequence similarity
is clustered around two conserved tryptophan residues, a characteristic
also described for SH3 and WW domains (21, 36). The crystal
structure analysis of the latter two modules revealed that the bulky
tryptophan residue is a central element for the three-dimensional
folding of the domain. Third, despite the evolutionary distance of the
organisms from which the SCAD-containing proteins were isolated, the
degree of sequence similarity between their SCAD regions is even higher than that found between PH domains or between certain SH2 domains (data
not shown). Finally, all four SCAD-containing proteins are linked to
cellular functions that involve the actin cytoskeleton. The known
isoforms of the neuron-specific drebrin proteins (A, E1, and E2)
directly bind actin and regulate actin filament assembly (33). Drebrin E-actin complexes accumulate in the
submembranous, cortical cytoplasm, and overexpression of drebrin E in
fibroblasts results in the formation of cell processes. The yeast
F-actin-binding protein Abp-1 is associated with the cortical
cytoskeleton and plays a role in endocytosis (10, 41). The
latter function is dependent on the Abp-1 SH3 domain, which binds to
the adenylate cyclase-associated protein CAP, a positive regulator of
cyclic AMP synthesis (13, 41). Most strikingly, coactosin,
which does not possess amino acids in addition to the SCAD region,
binds to F-actin (9). This enhances F-actin polymerization
by antagonizing the binding of F-actin-capping proteins, which retard
the process (30). The colocalization of SH3P7 with actin
fibers and its sensitivity to cytochalasin D show that SH3P7 is also
linked to the actin cytoskeleton and may participate in its reorganization.
The functional significance of the cytoskeleton for lymphocyte
development and activation is now established. A stimulation-dependent and -independent association of cytoskeletal components with both B-
and T-cell antigen receptors has been reported previously (4, 20,
24, 31). Antigen-mediated reorganization of the
microtubule-organizing center in T cells and the F-actin assembly in B
cells is ITAM dependent (6, 19). A functional actin
cytoskeleton is thought to be a prerequisite for the internalization of
BCR-antigen complexes leading to antigen processing and presentation to
T cells. The most compelling and direct evidence that the actin
cytoskeleton is required for antigen receptor signaling is provided by
the analysis of mice deficient for the vav proto-oncogene
(12, 15). Tyrosine-phosphorylated Vav exhibits GDP/GTP
exchange activity for the Rho-like small GTPase Rac 1 (7),
which regulates reorganization of the cytoskeleton (27). In
the absence of Vav, T cells fail to induce antigen-mediated actin
polymerization and clustering of T-cell receptors into patches and caps
(12, 15). Other signaling defects include reduced
Ca2+ mobilization and NFAT-mediated transcriptional
activation. These observations help to explain the impaired development
of T and B cells in Vav-deficient mice (12, 15, 37, 47). A
physical association of Vav with components of the cytoskeleton was
demonstrated by coimmunoprecipitation with talin and vinculin
(12). Coupling of Vav to antigen receptors may involve its
association to SLP-76 in T cells (40, 44) and to SLP-65 in B
cells (43). These results indicate that in lymphocytes, the
cytoskeleton plays a role not only in the organization of cell shape
and morphology but also in the structural organization of early and
late signaling events. The molecular mechanisms underlying these
processes are unclear. Our data implicate SH3P7 as a second effector
molecule that transmits signals from lymphocyte antigen receptors to
the cytoskeleton. Like other adapter proteins, SH3P7 may act as
regulatory element to achieve and maintain specificity within the
network of signaling proteins.
 |
ACKNOWLEDGMENTS |
We thank M. Reth for generous support and many critical discussions.
This work is supported by the Deutsche Forschungsgemeinschaft through
grant SFB388 and the Leibniz prize to M. Reth.
 |
FOOTNOTES |
*
Corresponding author. Mailing address:
Max-Planck-Institut für Immunbiologie, Stübeweg 51, 79108 Freiburg, Germany. Phone: 49-761-5108-438. Fax: 49-761-5108-423. E-mail: wienands{at}immunbio.mpg.de.
 |
REFERENCES |
| 1.
|
Baumann, G.,
D. Maier,
F. Freuler,
C. Tschopp,
K. Baudisch, and J. Wienands.
1994.
In vitro characterization of major ligands for Src homology 2 domains derived from tyrosine kinases, from the adaptor protein SHC and from GTPase-activating protein in Ramos B cells.
Eur. J. Immunol.
42:1799-1807.
|
| 2.
|
Borg, J.-P., and B. Margolis.
1998.
Function of PTB domains.
Curr. Top. Microbiol. Immunol.
228:23-38[Medline].
|
| 3.
|
Bork, P., and M. Sudol.
1994.
The WW domain: a signalling site in dystrophin.
Trends Biochem. Sci.
19:531-533[Medline].
|
| 4.
|
Caplan, S.,
S. Zeliger,
L. Wang, and M. Baniyash.
1995.
Cell-surface-expressed T-cell antigen-receptor chain is associated with the cytoskeleton.
Proc. Natl. Acad. Sci. USA
92:4768-4772[Abstract/Free Full Text].
|
| 5.
|
Carpino, N.,
D. Wisniewski,
A. Strife,
D. Marshak,
R. Kobayashi,
B. Stillman, and B. Clarkson.
1997.
p62dok: a constitutively tyrosine-phosphorylated GAP-associated protein in chronic myelogenous leukemia progenitor cells.
Cell
88:197-204[Medline].
|
| 6.
|
Cox, D.,
P. Chang,
T. Kurosaki, and S. Greenberg.
1996.
Syk tyrosine kinase is required for immunoreceptor tyrosine activation motif-dependent actin assembly.
J. Biol. Chem.
271:16597-16602[Abstract/Free Full Text].
|
| 7.
|
Crespo, P.,
K. E. Schuebel,
A. A. Ostrom,
J. S. Gutkind, and X. R. Bustelo.
1997.
Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product.
Nature
385:169-172[Medline].
|
| 8.
|
DeFranco, A. L.
1997.
The complexity of signaling pathways activated by the BCR.
Curr. Opin. Immunol.
9:296-308[Medline].
|
| 9.
|
deHostos, E. L.,
B. Bradtke,
F. Lottspeich, and G. Gerisch.
1993.
Coactosin, a 17 kDa F-actin binding protein from Dictyostelium discoideum.
Cell Motil. Cytoskelet.
26:181-191[Medline].
|
| 10.
|
Drubrin, D. G.,
J. Mulholland,
Z. Zhu, and D. Botstein.
1990.
Homology of a yeast actin-binding protein to signal transduction proteins and myosin-1.
Nature
343:288-290[Medline].
|
| 11.
|
Feng, S.,
J. K. Chen,
H. Yu,
J. A. Simon, and S. L. Schreiber.
1994.
Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions.
Science
266:1241-1247[Abstract/Free Full Text].
|
| 12.
|
Fischer, K.-D.,
Y.-Y. Kong,
K. Tedford,
L. E. M. Marengère,
I. Kozieradzki,
T. Sasaki,
M. Starr,
G. Chan,
S. Gardener,
M. P. Nghiem,
D. Bouchard,
M. Barbacid,
A. Bernstein, and J. M. Penninger.
1998.
Vav is a regulator of the cytoskeletal reorganization mediated by the T-cell receptor.
Curr. Biol.
8:554-562[Medline].
|
| 13.
|
Freemann, N. L.,
T. Lila,
K. Mintzer,
Z. Chen,
A. J. Pahk,
R. Ren,
D. G. Drubin, and J. Field.
1996.
A conserved proline-rich region of the Saccharomyces cerevisiae cyclase-associated protein binds SH3 domains and modulates cytoskeletal localization.
Mol. Cell. Biol.
16:548-556[Abstract].
|
| 14.
|
Gold, M. R.,
M. T. Crowley,
G. A. Martin,
F. McCormick, and A. L. DeFranco.
1993.
Targets of B lymphocyte antigen receptor signal transduction include the p21ras GTPase-activating protein (GAP) and two GAP-associated proteins.
J. Immunol.
150:377-386[Abstract].
|
| 15.
|
Holsinger, L. J.,
I. A. Graef,
W. Swat,
T. Chi,
D. M. Bautista,
L. Davidson,
R. S. Lewis,
F. W. Alt, and G. R. Crabtree.
1998.
Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction.
Curr. Biol.
8:563-572[Medline].
|
| 16.
|
Kurosaki, T.
1997.
Molecular mechanisms in B cell antigen receptor signaling.
Curr. Opin. Immunol.
9:309-318[Medline].
|
| 17.
|
Langdon, W. Y.,
J. W. Hartley,
S. P. Klinken,
S. K. Ruscetti, and H. C. D. Morse.
1989.
v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas.
Proc. Natl. Acad. Sci. USA
86:1168-1172[Abstract/Free Full Text].
|
| 18.
|
Lemmon, M. A.,
M. Falasca,
K. M. Ferguson, and J. Schlessinger.
1997.
Regulatory recruitment of signalling molecules to the cell membrane by pleckstrin-homology domains.
Trends Cell Biol.
7:237-242.
|
| 19.
|
Lowin-Kropf, B.,
V. Smith Shapiro, and A. Weiss.
1998.
Cytoskeletal polarization of T cells is regulated by an immunoceptor tyrosine-based activation motif-dependent mechanism.
J. Cell Biol.
140:861-971[Abstract/Free Full Text].
|
| 20.
|
Marano, N.,
D. Holowka, and B. Baird.
1989.
Bivalent binding of an anti-CD3 antibody to Jurkat cells induces association of the T cell receptor complex with cytoskeleton.
J. Immunol.
143:931-938[Abstract].
|
| 21.
|
Mayer, B. J., and M. J. Eck.
1995.
Minding your p's and q's.
Curr. Biol.
4:364-367.
|
| 22.
|
Mayer, B. J., and G. Gupta.
1998.
Functions of SH2 and SH3 domains.
Curr. Top. Microbiol. Immunol.
228:1-22[Medline].
|
| 23.
|
Panchamoorthy, G.,
T. Fukazawa,
S. Miyake,
S. Soltoff,
K. Reedquist,
B. Druker,
S. Shoelson,
L. Cantley, and H. Band.
1996.
p120cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphytidylinositol 3-kinase.
J. Biol. Chem.
271:3187-3194[Abstract/Free Full Text].
|
| 24.
|
Park, J. Y., and J. Jongstra-Bilen.
1997.
Interactions between membrane IgM and the cytoskeleton involve the cytoplasmic domain of the immunoglobulin receptor.
Eur. J. Immunol.
27:3001-3009[Medline].
|
| 25.
|
Pawson, T.
1995.
Protein modules and signalling networks.
Nature
373:573-580[Medline].
|
| 26.
|
Posas, F., and H. Saito.
1997.
Osmotic activation of the HOG MAPK pathway via Ste11p MAPKKK: scaffold role of PBS2p MAPKK.
Science
276:1702-1705[Abstract/Free Full Text].
|
| 27.
|
Reif, K., and D. A. Cantrell.
1998.
Networking Rho family GTPases in lymphocytes.
Immunity
8:395-401[Medline].
|
| 28.
|
Ren, R.,
B. J. Mayer,
P. Cicchetti, and D. Baltimore.
1993.
Identification of a 10-amino acid proline-rich SH3 binding site.
Science
259:1157-1161[Abstract/Free Full Text].
|
| 29.
|
Reth, M., and J. Wienands.
1997.
Initiation and processing of signals from the B cell antigen receptor.
Annu. Rev. Immunol.
15:453-479[Medline].
|
| 30.
|
Röhrig, U.,
G. Gerisch,
L. Morozova,
M. Schleicher, and A. Wegner.
1995.
Coactosin interferes with the capping of actin filaments.
FEBS Lett.
374:284-286[Medline].
|
| 31.
|
Rozdzial, M. M.,
B. Malissen, and T. H. Finkel.
1995.
Tyrosine-phosphorylated T cell receptor chain associates with the actin cytoskeleton upon activation of mature T lymphocytes.
Immunity
3:623-633[Medline].
|
| 32.
|
Sakai, R.,
A. Iwamatsu,
N. Hirano,
S. Ogawa,
T. Tanaka,
H. Mano,
Y. Yazaki, and H. Hirai.
1994.
A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner.
EMBO J.
13:3748-3756[Medline].
|
| 33.
|
Shirao, T.
1995.
The roles of microfilament-associated proteins, drebrins, in brain morphogenesis.
J. Biochem.
117:231-236[Abstract/Free Full Text].
|
| 34.
|
Songyang, Z.,
S. E. Shoelson,
M. Chaudhuri,
G. Gish,
T. Pawson,
W. G. Haser,
F. King,
T. Roberts,
S. Ratnofsky,
R. J. Lechleider,
B. G. Neel,
R. B. Birge,
J. E. Fajardo,
M. M. Chou,
H. Hanafusa,
B. Schaffhausen, and L. C. Cantley.
1993.
SH2 domains recognize specific phosphopeptide sequences.
Cell
72:767-778[Medline].
|
| 35.
|
Sparks, A. B.,
N. G. Hoffmann,
S. J. McConnell,
D. M. Fowlkes, and B. K. Kay.
1996.
Cloning of ligand targets: systematic isolation of SH3 domain-containing proteins.
Nat. Biotechnol.
14:741-744[Medline].
|
| 36.
|
Staub, O., and D. Rotin.
1996.
WW domains.
Structure
4:495-499[Medline].
|
| 37.
|
Tarakhovsky, A.,
M. Turner,
S. Schaal,
P. J. Mee,
L. P. Duddy,
K. Rajewsky, and V. L. Tybulewicz.
1995.
Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav.
Nature
374:467-470[Medline].
|
| 38.
|
Tezuka, T.,
H. Umemori,
N. Fusaki,
T. Yagi,
M. Takata,
T. Kurosaki, and T. Yamamoto.
1996.
Physical and functional association of the cbl proto-oncogene product with an Src-family protein tyrosine kinase, p53/56lyn, in the B cell antigen receptor-mediated signaling.
J. Exp. Med.
183:675-680[Abstract/Free Full Text].
|
| 39.
|
Tsunoda, S.,
J. Sierralta,
Y. Sun,
R. Bodner,
E. Suzuki,
A. Becker,
M. Socolich, and C. S. Zuker.
1997.
A multivalent PDZ-domain protein assembles signalling complexes in a G-protein-coupled cascade.
Nature
388:243-249[Medline].
|
| 40.
|
Tuosto, L.,
F. Michel, and O. Acuto.
1996.
p95vav associates with tyrosine-phosphorylated SLP-76 in antigen-stimulated T cells.
J. Exp. Med.
184:1161-1166[Abstract/Free Full Text].
|
| 41.
|
Wesp, A.,
L. Hicke,
J. Palecek,
R. Lombardi,
T. Aust,
A. L. Munn, and H. Riezman.
1997.
End4p/Sla2p interacts with actin-associated proteins for endocytosis in Saccharomyces cerevisiae.
Mol. Biol. Cell
8:2291-2306[Abstract/Free Full Text].
|
| 42.
|
Wienands, J.,
O. Larbolette, and M. Reth.
1996.
Evidence for a preformed transducer complex organized by the B cell antigen receptor.
Proc. Natl. Acad. Sci. USA
93:7865-7870[Abstract/Free Full Text].
|
| 43.
|
Wienands, J.,
J. Schweikert,
B. Wollscheid,
H. Jumaa,
P. J. Nielsen, and M. Reth.
1998.
SLP-65: a new signaling component in B lymphocytes which requires expression of the antigen receptor for phosphorylation.
J. Exp. Med.
188:791-795[Abstract/Free Full Text].
|
| 44.
|
Wu, J.,
D. G. Motto,
G. A. Koretzky, and A. Weiss.
1996.
Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation.
Immunity
4:593-602[Medline].
|
| 45.
|
Yamanashi, Y., and D. Baltimore.
1997.
Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok.
Cell
88:205-211[Medline].
|
| 46.
|
Yamanashi, Y.,
M. Okada,
T. Semba,
T. Yamori,
H. Umemori,
S. Tsunasawa,
K. Toyoshima,
D. Kitamura,
T. Watanabe, and T. Yamamoto.
1993.
Identification of HS1 protein as a major substrate of protein-tyrosine kinase(s) upon B-cell antigen receptor-mediated signaling.
Proc. Natl. Acad. Sci. USA
90:3631-3635[Abstract/Free Full Text].
|
| 47.
|
Zhang, R.,
F. W. Alt,
L. Davidson,
S. H. Orkin, and W. Swat.
1995.
Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene.
Nature
374:470-473[Medline].
|
Molecular and Cellular Biology, February 1999, p. 1539-1546, Vol. 19, No. 2
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Haeckel, A., Ahuja, R., Gundelfinger, E. D., Qualmann, B., Kessels, M. M.
(2008). The Actin-Binding Protein Abp1 Controls Dendritic Spine Morphology and Is Important for Spine Head and Synapse Formation. J. Neurosci.
28: 10031-10044
[Abstract]
[Full Text]
-
Onabajo, O. O., Seeley, M. K., Kale, A., Qualmann, B., Kessels, M., Han, J., Tan, T.-H., Song, W.
(2008). Actin-Binding Protein 1 Regulates B Cell Receptor-Mediated Antigen Processing and Presentation in Response to B Cell Receptor Activation. J. Immunol.
180: 6685-6695
[Abstract]
[Full Text]
-
Zhang, J., Suzuki, K., Hitomi, T., Siraganian, R. P.
(2007). TOM1L1 Is a Lyn Substrate Involved in Fc{epsilon}RI Signaling in Mast Cells. J. Biol. Chem.
282: 37669-37677
[Abstract]
[Full Text]
-
Gevrey, J.-C., Isaac, B. M., Cox, D.
(2005). Syk Is Required for Monocyte/Macrophage Chemotaxis to CX3CL1 (Fractalkine). J. Immunol.
175: 3737-3745
[Abstract]
[Full Text]
-
Han, J., Shui, J.-W., Zhang, X., Zheng, B., Han, S., Tan, T.-H.
(2005). HIP-55 Is Important for T-Cell Proliferation, Cytokine Production, and Immune Responses. Mol. Cell. Biol.
25: 6869-6878
[Abstract]
[Full Text]
-
Denis, F. M., Benecke, A., Di Gioia, Y., Touw, I. P., Cayre, Y. E., Lutz, P. G.
(2005). PRAM-1 Potentiates Arsenic Trioxide-induced JNK Activation. J. Biol. Chem.
280: 9043-9048
[Abstract]
[Full Text]
-
Le Bras, S., Foucault, I., Foussat, A., Brignone, C., Acuto, O., Deckert, M.
(2004). Recruitment of the Actin-binding Protein HIP-55 to the Immunological Synapse Regulates T Cell Receptor Signaling and Endocytosis. J. Biol. Chem.
279: 15550-15560
[Abstract]
[Full Text]
-
Kay-Jackson, P. C., Goatley, L. C., Cox, L., Miskin, J. E., Parkhouse, R. M. E., Wienands, J., Dixon, L. K.
(2004). The CD2v protein of African swine fever virus interacts with the actin-binding adaptor protein SH3P7. J. Gen. Virol.
85: 119-130
[Abstract]
[Full Text]
-
Han, J., Kori, R., Shui, J.-W., Chen, Y.-R., Yao, Z., Tan, T.-H.
(2003). The SH3 Domain-containing Adaptor HIP-55 Mediates c-Jun N-terminal Kinase Activation in T Cell Receptor Signaling. J. Biol. Chem.
278: 52195-52202
[Abstract]
[Full Text]
-
Hou, P., Estrada, L., Kinley, A. W., Parsons, J. T., Vojtek, A. B., Gorski, J. L.
(2003). Fgd1, the Cdc42 GEF responsible for Faciogenital Dysplasia, directly interacts with cortactin and mAbp1 to modulate cell shape. Hum Mol Genet
12: 1981-1993
[Abstract]
[Full Text]
-
Fenster, S. D., Kessels, M. M., Qualmann, B., Chung, W. J., Nash, J., Gundelfinger, E. D., Garner, C. C.
(2003). Interactions between Piccolo and the Actin/Dynamin-binding Protein Abp1 Link Vesicle Endocytosis to Presynaptic Active Zones. J. Biol. Chem.
278: 20268-20277
[Abstract]
[Full Text]
-
HASLER, P., ZOUALI, M.
(2001). B cell receptor signaling and autoimmunity. FASEB J.
15: 2085-2098
[Abstract]
[Full Text]
-
Kessels, M. M., Engqvist-Goldstein, A. E.Y., Drubin, D. G., Qualmann, B.
(2001). Mammalian Abp1, a Signal-responsive F-Actin-binding Protein, Links the Actin Cytoskeleton to Endocytosis Via the GTPase Dynamin. JCB
153: 351-366
[Abstract]
[Full Text]
-
Qualmann, B., Kessels, M. M., Kelly, R. B.
(2000). Molecular Links between Endocytosis and the Actin Cytoskeleton. JCB
150: F111-F116
[Abstract]
[Full Text]
-
Keon, B., Jedrzejewski, P., Paul, D., Goodenough, D.
(2000). Isoform specific expression of the neuronal F-actin binding protein, drebrin, in specialized cells of stomach and kidney epithelia. J. Cell Sci.
113: 325-336
[Abstract]
-
Kessels, M. M., Engqvist-Goldstein, A. E. Y., Drubin, D. G.
(2000). Association of Mouse Actin-binding Protein 1 (mAbp1/SH3P7), an Src Kinase Target, with Dynamic Regions of the Cortical Actin Cytoskeleton in Response to Rac1 Activation. Mol. Biol. Cell
11: 393-412
[Abstract]
[Full Text]
-
RETH, M., WIENANDS, J.
(1999). The Maintenance and the Activation Signal of the B-cell Antigen Receptor. Cold Spring Harb Symp Quant Biol
64: 323-328
[Abstract]
-
Fucini, R. V., Chen, J.-L., Sharma, C., Kessels, M. M., Stamnes, M.
(2002). Golgi Vesicle Proteins Are Linked to the Assembly of an Actin Complex Defined by mAbp1. Mol. Biol. Cell
13: 621-631
[Abstract]
[Full Text]